Clostridium Histolyticum Collagenase Injection for Urethral Disease
Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease: a Prospective, Single-center, Open-label Study
Sponsor: University of South Florida
A PHASE2 clinical study on Urethral Stricture, this trial is completed. The trial is conducted by University of South Florida and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Sep 2022 — Dec 2023 [monthly]
Recruiting PHASE2
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE2
▶ Show 7 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2019 — Apr 2020 [monthly]
Not Yet Recruiting PHASE2
Status: Unknown Status → Not Yet Recruiting
-
Jul 2019 — Oct 2019 [monthly]
Unknown Status PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Jul 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of South Florida
For direct contact, visit the study record on ClinicalTrials.gov .